OPKO HEALTH, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($328.4m) ($188.9m) ($53.2m) ($225.7m)
Net Income (Loss) Attributable to Parent ($25.1m) ($308.9m) ($153.0m) ($314.9m) $30.6m ($30.1m) ($328.4m) ($188.9m) ($53.2m) ($225.7m)
Net Income (Loss) Available to Common Stockholders, Basic ($25.1m) ($308.9m) ($153.0m) ($314.9m) $30.6m ($30.1m) ($328.4m) ($188.9m) ($53.2m) ($225.7m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($25.1m) ($308.9m) ($153.0m)
Net Income (Loss) Attributable to Noncontrolling Interest $0 $0
Depreciation, Depletion and Amortization $96.6m $102.1m $97.3m $93.8m $85.4m $78.7m $108.7m $105.3m $98.2m $91.6m
Depreciation $33.3m $30.6m $29.4m $29.0m $29.0m $28.4m $20.9m $19.3m $15.6m $13.7m
Amortization of Debt Issuance Costs $237k $224k $187k $995k $847k $785k $1.2m $1.2m $2.0m $5.2m
Amortization of Intangible Assets $64.4m $84.7m $67.9m $64.8m $56.4m $50.3m $87.8m $86.0m $82.6m $77.9m
Depreciation Amortization Depletion $108.7m $105.3m $98.2m $91.6m
Deferred Income Tax Expense (Benefit) ($61.5m) $16.1m ($35.1m) $4.3m $15.6m $10.2m ($74.4m) $146k $14.7m ($15.0m)
Deferred Income Tax ($74.4m) $146k $14.7m ($15.0m)
Deferred Tax ($74.4m) $146k $14.7m ($15.0m)
Share-based Payment Arrangement, Noncash Expense $42.7m $28.3m $21.8m $13.4m $8.9m $13.6m $18.5m $11.4m $11.0m $10.7m
Share-based Payment Arrangement, Expense $11.4m $11.0m $10.7m
Goodwill, Impairment Loss $11.7m $26.2m $0 $0 $0
Impairment of Intangible Assets, Finite-lived $0 $0 $1.0m
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $13.2m
Asset Impairment Charge $0 $0 $0 $1.0m
Gain (Loss) on Disposition of Assets $2.3m ($8.7m) ($46k) ($739k) $10.7m $33.9m $455k ($1.3m) $63.4m $3.2m
Gain (Loss) on Disposition of Other Assets $2.3m ($8.7m) $46k $739k ($10.7m) ($33.9m) $18.6m $0 $121.5m $101.6m
Gain (Loss) on Disposition of Property Plant Equipment $1.4m $7.3m $1.2m $671k $245k $31.5m $2.0m $2.7m $242k $287k
Gain (Loss) on Extinguishment of Debt ($284k) $0 $0
Income (Loss) from Equity Method Investments ($7.7m) ($14.5m) ($14.5m) ($629k) ($383k) ($107k) ($18k) ($29k)
Income Tax Expense (Benefit) ($56.1m) $18.9m ($38.7m) $7.1m $17.6m $15.5m ($63.5m) $4.4m $42.8m ($15.7m)
Interest Expense Nonoperating $47.5m $108.5m
Other Nonoperating Income (Expense) $3.9m $10.5m $1.5m ($11.3m) $12.7m ($14.8m) ($155.8m) ($17.0m) $206.9m ($29.9m)
Earnings (Loss)es From Equity Investments $383k $107k $18k $29k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $25.6m ($58.0m) ($20.4m) ($7.4m) $150.4m ($5.2m) ($128.6m) ($3.4m) $220k ($30.2m)
Increase (Decrease) in Inventories $6.6m $3.5m ($4.6m) $12.1m $77.6m ($30.7m) ($13.7m) ($15.2m) ($4.2m) $4.1m
Increase (Decrease) in Accounts Payable ($19.8m) $20.2m ($26.1m) $15.6m $37.2m ($10.8m) ($9.4m) $2.8m ($20.7m) ($14.2m)
Deconsolidation, Gain (Loss), Amount $0 $0
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $2.3m ($8.7m) $46k $739k ($10.7m) ($33.9m) ($455k) $1.3m $121.5m $101.6m
Equity Securities, FV-NI, Gain (Loss) $2.3m ($8.7m) $46k $739k $10.4m ($1.8m) ($3.6m) ($532k) $73.9m $4.1m
Equity Securities, FV-NI, Realized Gain (Loss) $2.3m ($8.7m) $2.8m ($7.4m) $10.3m $3.0m $0 $0 ($54.0m) ($4.3m)
Equity Securities, FV-NI, Unrealized Gain (Loss) $2.3m $2.9m ($7.4m) $52k ($4.8m) ($3.6m) ($532k) $19.8m ($240k)
Foreign Currency Transaction Gain (Loss), before Tax $800k $1.4m $1.9m $400k $1.6m ($1.4m) ($1.8m) $1.2m ($3.8m) ($2.0m)
Gain (Loss) on Investments ($7.7m) ($14.5m) ($14.5m) ($2.9m) ($480k) ($629k) ($383k) ($107k)
Goodwill $704.6m $717.1m $700.2m $671.9m $680.6m $520.6m $595.9m $598.3m $529.3m $484.3m
Induced Conversion of Convertible Debt Expense $0 $0 $32.6m
Inventory Write-down $0 $5.4m $1.9m $2.3m $4.4m $6.5m $4.1m $8.1m $2.1m $4.1m
Investment Income, Interest $4.0m $8.4m $14.8m
Nonoperating Income (Expense) ($271k) $4.5m ($6.1m) ($30.9m) ($9.0m) ($32.8m) ($165.3m) ($27.3m) $141.7m ($124.0m)
Operating Expenses $1.3b $1.3b $1.2b $1.2b $1.4b $1.8b $1.2b $1.0b
Beginning Cash Position $134.7m $153.2m $95.9m $445.6m
Cash Flow From Continuing Financing Activities $23.0m ($11.3m) $184.2m ($118.1m)
Cash Flow From Continuing Investing Activities $91.0m ($18.2m) $352.2m $230.3m
Change In Account Payable ($9.4m) $2.8m ($20.7m) ($14.2m)
Change In Accrued Expense ($91.1m) ($5.5m) $48.7m ($47.8m)
Change In Inventory $13.7m $15.2m $4.2m ($4.1m)
Change In Other Current Assets ($1.5m) $6.9m ($3.7m) ($5.4m)
Change In Other Working Capital $2.4m ($1.0m) $3.9m $178k
Change In Payable ($9.4m) $2.8m ($20.7m) ($14.2m)
Change In Payables And Accrued Expense ($100.5m) ($2.6m) $28.0m ($62.1m)
Change In Receivables $128.6m $3.4m ($220k) $30.2m
Change In Working Capital $42.7m $21.8m $32.2m ($41.2m)
Changes In Account Receivables $128.6m $3.4m ($220k) $30.2m
Changes In Cash $18.8m ($57.7m) $352.9m ($66.3m)
End Cash Position $153.2m $95.9m $445.6m $382.7m
Financing Cash Flow $23.0m ($11.3m) $184.2m ($118.1m)
Free Cash Flow ($119.8m) ($44.5m) ($208.5m) ($190.8m)
Gain Loss On Sale Of Business $0 ($18.6m) $0
Gain Loss On Sale Of PPE ($455k) $1.3m ($63.4m) ($3.2m)
Investing Cash Flow $91.0m ($18.2m) $352.2m $230.3m
Net Business Purchase And Sale ($1.8m) ($5.0m) $210.4m $190.1m
Net PPE Purchase And Sale $2.0m $2.7m $242k $287k
Operating Gains Losses ($18.6m) $1.4m ($184.9m) ($72.1m)
Other Non Cash Items $2.6m $2.9m $12.9m $71.5m
Proceeds From Stock Option Exercised ($774k) ($272k) ($208k) ($256k)
Purchase Of Business ($1.8m) ($5.0m) $0 ($7.7m)
Repurchase Of Capital Stock $0 $0 ($90.2m) ($47.0m)
Sale Of Business $0 $0 $210.4m $197.8m
Sale Of PPE $2.0m $2.7m $242k $287k
Stock Based Compensation $18.5m $11.4m $11.0m $10.7m
Unrealized Gain Loss On Investment Securities $153.8m $17.6m ($114.4m) $623k
Gain (Loss) on Derivative Instruments, Net, Pretax $2.8m $52k $3.0m $174k $50k $846k $649k ($781k) ($26.2m) ($429k)
Net Cash Provided by (Used in) Operating Activities $32.0m ($92.1m) ($109.1m) ($172.5m) $39.5m $38.3m ($95.2m) ($28.2m) ($183.5m) ($178.5m)
Cash flows from investing activities:
Capital Expenditure ($24.6m) ($16.3m) ($25.0m) ($12.3m)
Capital Expenditure Reported $18.5m $46.5m $27.9m $12.7m $33.7m $32.2m ($24.6m) ($16.3m) ($25.0m) ($12.3m)
Payments to Acquire Businesses, Net of Cash Acquired ($15.9m) $0 $0 $0 $0 $4.0m $1.8m $0 $0
Payments to Acquire Investments $14.4m $9.6m $1.0m $1.2m $0 $2.0m $0 $5.0m $0
Net Investment Purchase And Sale $115.4m $364k $166.6m $52.2m
Gain (Loss) on Sale of Investments ($2.3m) $8.7m ($113k) $0 $18.6m $0
Sale Of Investment $115.4m $364k $166.6m $52.2m
Payments for (Proceeds from) Other Investing Activities $0 ($2.2m)
Net Cash Provided by (Used in) Investing Activities ($20.7m) ($46.7m) ($26.1m) ($13.3m) ($18.3m) $35.9m $91.0m ($18.2m) $352.2m $230.3m
Cash flows from financing activities:
Issuance Of Debt $1.1b $671.7m $939.4m $33.0m
Long Term Debt Issuance $1.1b $671.7m $939.4m $33.0m
Net Issuance Payments Of Debt $23.7m ($11.0m) $288.0m ($70.8m)
Net Long Term Debt Issuance $23.7m ($11.0m) $288.0m ($70.8m)
Long Term Debt Payments ($1.0b) ($682.7m) ($651.5m) ($103.8m)
Repayment Of Debt ($1.0b) ($682.7m) ($651.5m) ($103.8m)
Proceeds from Issuance of Common Stock $92.5m $76.1m $0 $0 $221.7m $0 $0
Net Common Stock Issuance $0 $0 ($90.2m) ($47.0m)
Payments for Repurchase of Common Stock $90.2m $47.0m
Common Stock Payments $0 $0 ($90.2m) ($47.0m)
Proceeds from (Payments to) Noncontrolling Interests $0 $0
Net Other Financing Charges ($188k) ($13.4m)
Net Cash Provided by (Used in) Financing Activities ($35.2m) $61.0m $140.9m $175.2m ($35.1m) ($10.4m) $23.0m ($11.3m) $184.2m ($118.1m)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($477k) $686k ($1.4m) ($339k) $388k ($3.2m) $3.4m
Effect Of Exchange Rate Changes ($339k) $388k ($3.2m) $3.4m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($11.0m) ($13.2m) $62.5m $18.5m ($57.3m) $349.7m ($62.9m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $85.5m $72.2m $134.7m $153.2m $95.9m $445.6m $382.7m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported $18.5m ($57.3m) $349.7m ($62.9m)
Interest Paid, Excluding Capitalized Interest, Operating Activities $2.9m $1.3m $2.1m $11.9m $10.9m $8.5m $7.4m $8.1m $20.9m $37.9m
Income Taxes Paid, Net ($27.1m) $5.4m ($1.4m) $2.7m ($903k) $6.0m $8.0m $3.7m $10.0m $24.5m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.